ISPM — Integrated Spine & Pain Management — is a clinical framework for organising pain and spine care, not a new method shown to be superior to others. It rests on four principles: individualised assessment, shared decision-making, outcome-based reassessment, and scientific integrity with transparency.
ISPM — Integrated Spine & Pain Management is a clinical framework for integrated pain and spine care. It draws on the development of multidisciplinary pain medicine since the 1950s and is applied through four principles: individualised assessment, shared decision-making, outcome-based reassessment, and scientific integrity with transparency. It is not a technology, and not a treatment shown to be superior to others.
Why treating the source is not always enough
Pain medicine has advanced considerably in recent decades, both in understanding pain mechanisms and in the means of diagnosis and treatment. Even so, treating the anatomical source of pain does not always lead to a full return to function.
Two patients can present with similar imaging findings and experience pain of different intensities and different degrees of limitation. In one, pain mainly affects physical activity; in another it also disrupts sleep, work, mood and relationships.
These differences illustrate that pain — chronic pain in particular — is not only the result of tissue damage but a complex experience shaped by biological, neurological, psychological and social factors. The multidisciplinary approach grew out of this.
John Bonica and the multidisciplinary clinic
Professor John J. Bonica (1917–1994) is regarded as one of the founders of modern pain medicine. Working as an anaesthesiologist during the Second World War he treated casualties with complex pain syndromes, and concluded that in many cases a single specialist is not enough.
In 1953 he published The Management of Pain, and in 1961 he established a multidisciplinary pain clinic at the University of Washington. His contribution lay not in developing a particular treatment but in an organisational change: moving from fragmented symptom care to a coordinated system.
In his 1977 paper, Basic Principles in Managing Chronic Pain, he described three components that remain relevant:
- Defined clinical responsibility. Each patient has an identified clinician who gathers the information and ensures continuity.
- Team working. Decisions are made by sharing information among the relevant professionals.
- Repeated discussion of difficult cases. Where the diagnosis or the response is unclear, both are revisited.
The central lesson: integration means coordinated assessment, decisions and accountability — not many treatments gathered in one location.
How the understanding of pain developed
In 1965 Melzack and Wall published gate control theory, showing that pain-related signalling is modulated within the nervous system. Melzack later developed the Neuromatrix model, emphasising the brain’s role in shaping the experience of pain.
In 1977 George Engel introduced the biopsychosocial model, under which understanding a person’s condition requires attention to the interaction of biological, psychological and social factors.
John Loeser distinguished nociception, the experience of pain, suffering and pain behaviour — a clinically important distinction, because a fall in pain intensity does not necessarily reflect the whole of the improvement. Sometimes better sleep, movement and self-efficacy are the meaningful achievement.
The revised IASP definition of 2020 recognises pain as a personal sensory and emotional experience influenced by multiple factors. None of this implies that pain is imaginary or that structural pathology can be ignored.
Norman Shealy and IDD — what is known and what is not
C. Norman Shealy, a neurosurgeon and pain researcher, was among those who advanced approaches combining medical treatment, rehabilitation, attention to stress and lifestyle. His name is also historically connected to Intervertebral Differential Dynamics (IDD Therapy).
In 2005 Shealy and colleagues published a retrospective study of 33 patients with low back pain, reporting a fall in mean pain scores from 6.88 before treatment to 2.42 at the final session and 1.65 at one-year follow-up. A 2026 retrospective study assessed 21 patients with cervical or lumbar disc pathology and reported short-term improvement in pain and disability scores.
These data should be read carefully. Both studies are small and retrospective, without randomisation or an adequate control group, and with limited follow-up. In parallel, a randomised controlled trial published in 2009 found no benefit from this form of traction in low back pain.
The conclusion: improvement cannot confidently be attributed to IDD, and these findings cannot be converted into a promise of a result for any individual patient. Shealy’s historical importance is not in itself evidence that a technology associated with his name is effective.
What makes care genuinely integrated
A clinic offering a large number of treatments is not necessarily working in an integrated way. What matters is how the treatments are selected, combined and evaluated:
- Accurate medical diagnosis and an understanding of pain mechanisms.
- Individual, measurable treatment goals.
- Interventions chosen by clinical indication and the available evidence.
- Coordination among the professionals involved.
- Follow-up of the response to treatment.
- Reassessment and a change of plan when results are inadequate.
The purpose is not to move the patient through a number of sessions fixed in advance, but to match treatment to a changing clinical picture.
The four principles of ISPM
- Individualised assessment. Every patient has a distinct clinical and functional profile; there is no single plan for everyone.
- Shared decision-making. The patient understands the expected benefits, the risks, the alternatives and the uncertainties.
- Outcome-based reassessment. Pain, function, sleep and quality of life are followed — and when progress is inadequate, the diagnosis and the plan are revisited.
- Scientific integrity and transparency. Established evidence, preliminary findings and clinical experience are kept distinct, and the limits of the evidence are stated openly.
When to change direction
Continuing a treatment is not an end in itself. A lack of meaningful improvement should trigger reassessment — not an automatic commitment to a further block of sessions.
Referral for specialist or surgical assessment is sometimes the right decision, and surgery is not a failure of integrated care when it is the best option for the patient. Red flags — progressive neurological deterioration above all — require urgent evaluation.
Beyond pain reduction
Pain intensity matters, and so do walking tolerance, sleep quality, return to work, confidence in movement and quality of life. A patient can experience substantial improvement even when the pain has not disappeared entirely.
ISPM is presented here as a structured clinical framework grounded in established principles of pain medicine — not as a newly validated treatment or a claim of superiority. The goal is appropriate, coordinated and continuously reviewed care for the whole person.
How this is applied in the clinic — SAADA METHOD ←
References
- Bonica JJ. The Management of Pain. Lea & Febiger; 1953.
- Bonica JJ. Basic Principles in Managing Chronic Pain. Arch Surg. 1977;112(6):783–788.
- Melzack R, Wall PD. Pain Mechanisms: A New Theory. Science. 1965;150:971–979.
- Engel GL. The Need for a New Medical Model. Science. 1977;196:129–136.
- Melzack R. From the Gate to the Neuromatrix. Pain. 1999;Suppl 6:S121–S126.
- Raja SN, et al. The Revised IASP Definition of Pain. Pain. 2020;161(9):1976–1982.
- Shealy CN, Koladia N, Wesemann MM. Long-term effect analysis of IDD therapy in low back pain: a retrospective clinical pilot study. AJPM. 2005;15:93–97.
- Schimmel JJP, et al. No effect of traction in patients with low back pain: a randomized controlled trial of Intervertebral Differential Dynamics Therapy. Eur Spine J. 2009;18:1843–1850.
- Bartrom S, Syed E, Graham T. Quantifying Clinical Outcomes of IDD Therapy in Patients with Cervical and Lumbar Disc Bulges and Herniations. J Phys Med Rehabil. 2026;8(1):10–16.
Professional educational article. It is not a recommendation for any particular treatment and does not replace individual medical assessment. Observational findings are presented as preliminary evidence, not as proof of efficacy.
Frequently asked questions
Is ISPM a new treatment?
No. It is an organisational and clinical framework applying established principles of multidisciplinary pain medicine. It is not a technology or an intervention, and no claim of superiority over other approaches is made for it.
Is a clinic offering many treatments integrated?
Not necessarily. Having many modalities in one place does not make care integrated. What does is how treatments are selected, coordinated and reassessed against the result.
What is known about IDD Therapy?
Small observational studies have reported improvement in pain and function scores, alongside a randomised controlled trial that found no benefit from traction in low back pain. Because of methodological limitations, efficacy cannot be inferred, and these findings do not justify promising an outcome to any individual patient.
When is a surgical assessment appropriate?
When it is clinically indicated. A surgical referral is not a failure of conservative care, and progressive neurological red flags require urgent evaluation without delay.